Welcome To RevAid®

To help prevent embryo-fetal exposure, lenalidomide capsules, pomalidomide capsules and thalidomide capsules are available through a controlled distribution program called RevAid.

  • Prescribers who are registered and agree to meet all the conditions of the RevAid program will have access to lenalidomide, pomalidomide and thalidomide.
  • Patients who are enrolled in RevAid by their registered prescriber and agree to comply with the requirements of the RevAid program, will receive lenalidomide, pomalidomide or thalidomide.
  • Pharmacies registered with RevAid can dispense lenalidomide, pomalidomide and thalidomide.

For more information, please call 1-888-RevAid1 (1-888-738-2431).

Have an account?

Participating manufacturers:

  • Celgene Inc.
  • JAMP Pharma Group
  • Natco Pharma
  • Sandoz Canada
  • Taro Pharmaceuticals Inc.



Prescribers can register with the RevAid program online using the link below or by calling the RevAid program at 1-888-RevAid1 (1-888-738-2431).

Prescribers can assign delegates to complete administrative tasks on their behalf through their “My Delegates” tab:

New user – Prescribers must register new users

Existing user – Prescribers can add using the delegate’s RevAid ID

Only RevAid registered Pharmacies are able to order, store, and dispense medications that are available through the RevAid program. For more information, contact revaid@bms.com or by phone at 1-888-RevAid1 (1-888-738-2431).

Please note: if you have a patient awaiting therapy, please contact the RevAid Program at 1-888-RevAid1 (1-888-738-2431) to determine where the patient can receive medication.

Patients must be enrolled in RevAid to receive medications available through the program. Patients looking to enroll should contact their Prescriber.